Spain Ferrer’s CEO, Mario Rovirosa, outlines how he and a new management team have been building the foundation of the Spanish mid-cap’s transformation to become a specialty pharma company, a 180-degree shift that entailed the divestment of its generics portfolio, new affiliates across the world, and a more focused product pipeline.…
Global Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the last 30 years, bringing treatments to patients in developing countries with lysomal storage disorders who would otherwise not have access. Sibold outlines the persistent obstacles facing people with rare…
UAE Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets throughout the Gulf, mental health, and corporate social responsibility (CSR) initiatives in the region. The Gulf markets are very open to innovation and eager to bring the most…
Brazil Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research throughout Latin America on neglected diseases. This agreement establishes an exchange of know-how that will provide progress in public health policies in Brazil Patrice Matchaba, global head of corporate responsibility, Novartis…
Thailand Sumalee Kristarnin, country president of Novartis Thailand, shares the main initiatives of the affiliate in Thailand to take care of people, employees and patients. She highlights how the key priorities, put in place at the global level, are reflected in the local business, and how Novartis is trying to introduce…
Thailand Dr Armin Wiesler, general manager and head of Human Pharma at Boehringer Ingelheim (Thai) Ltd., explores how the affiliate has managed to achieve market-leading growth rates and addressed the challenges and opportunities inherent in the Thai pharma market for Boehringer Ingelheim. The pharma industry in Thailand is very dynamic…
Spain Jesús Sobrino, area head of UCB Iberia, and global leader for UCB’s Patients Experience Program, discusses the significance of the affiliate, which makes up 15 percent of UCB’s European sales, and their strategy to strengthen and grow their portfolio. Furthermore, he highlights the challenges of market access in the Spanish…
Cyprus Mario Sciberras, former general manager for Malta and Gibraltar became general manager for Cyprus, Malta, and Gibraltar in 2016. In this interview, he touches on themes of transparency, GSK’s positioning on the market and its vaccination strategy for the coming years. What have been your main priorities since taking over…
China Dami Qiu, founder and CEO of EMP, shares her personal story of how she decided to establish EMP two decades ago, the market opportunities in ultrasound medical equipment in China, and her groundbreaking poverty alleviation medical devices distribution platform for rural and community hospitals in China, which she hopes to…
Ecuador Ana Dolores Román, general manager at Pfizer Ecuador as well as the first woman to lead the affiliate in the country, discusses promoting medical education, increasing patient access to innovations and being a leading light for the local pharmaceutical industry. Besides being the GM of Pfizer, you are also the…
India A successful commercial leader, Annaswamy Vaidheesh, president of OPPI, VP South Asia and managing director at GSK India, talks about the tremendous work that the local affiliate is doing in the country in making innovative products available to patients and their recent GBP 100 million investment in manufacturing. Can you…
India A strong supporter of public-private partnerships, MSD’s managing director in India, Vivek Kamath, explains how the company’s collaborative approach is the key to enhancing their reputation, improving patient outcomes and tackling unmet medical needs in India. Mr. Kamath, you have worked for MSD for over four years and you…
See our Cookie Privacy Policy Here